China SXT Pharmaceuticals, Inc. (SXTC) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
SXTC currently has 13.8M outstanding shares. with significant dilution risk as 54.8M authorized shares could dilute existing holders by 398.1%. The company has significantly diluted shareholders by 520.47% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Nov 10, 2025 |
F-3 filing: China SXT Pharmaceuticals, Inc. may offer and sell up to $600,000,000 in the aggregate of Class A Ordinary Shares, warrants to purchase Class A Ordinary Shares, debt securities, units and rights or any combination of the foregoing. |
14M | 55M |
| Nov 10, 2025 |
POS AM filing: The company is removing unsold securities from registration after abandoning the offering, but $29,200,000 of securities were sold under the registration statement. |
14M | 55M |
| Jul 31, 2025 |
20-F filing | 13.8M shares outstanding |
14M | 230M |
| Oct 22, 2024 |
F-3 filing: China SXT Pharmaceuticals, Inc. is offering up to $120,000,000 in the aggregate of Ordinary Shares, warrants to purchase Ordinary Shares, debt securities, units and rights or any combination of the foregoing. |
2.2M | 230M |
| Aug 13, 2024 |
20-F filing | 2.2M shares outstanding |
2.2M | 55M |
| Jul 31, 2023 |
20-F filing | 11.4M shares outstanding |
11M | 55M |
| Jul 18, 2022 |
20-F filing | 40.6M shares outstanding |
41M | 55M |
| Aug 13, 2021 |
20-F filing | 15.5M shares outstanding |
16M | 55M |
| Feb 02, 2021 |
F-3 filing: China SXT Pharmaceuticals, Inc. is offering Ordinary Shares, preferred shares, warrants to purchase Ordinary Shares or preferred shares, debt securities, rights or any combination of the foregoing, either individually or as units comprised of one or more of the other securities, with an aggregate offering price not exceeding $40,000,000. |
35M | 55M |
| Jul 31, 2020 |
20-F filing | 34.7M shares outstanding |
35M | 0 |